166 related articles for article (PubMed ID: 8390281)
1. Refinement of an indirect immunotoxin assay of monoclonal antibodies recognising the human small cell lung cancer cluster 2 antigen.
Derbyshire EJ; de Leij L; Wawrzynczak EJ
Br J Cancer; 1993 Jun; 67(6):1242-7. PubMed ID: 8390281
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic properties of a ricin A chain immunotoxin recognising the cluster-5A antigen associated with human small-cell lung cancer.
Derbyshire EJ; Stahel RA; Wawrzynczak EJ
Cancer Immunol Immunother; 1992; 35(6):417-20. PubMed ID: 1327529
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibodies recognising the cluster 2 antigen associated with human small cell lung cancer mediate the toxic effects of ricin A chain in an indirect assay of immunotoxin cytotoxicity.
Derbyshire EJ; Wawrzynczak EJ
Br J Cancer Suppl; 1991 Jun; 14():74-7. PubMed ID: 1645578
[TBL] [Abstract][Full Text] [Related]
4. Selective cytotoxic effects of a ricin A chain immunotoxin made with the monoclonal antibody SWA11 recognising a human small cell lung cancer antigen.
Wawrzynczak EJ; Derbyshire EJ; Henry RV; Parnell GD; Smith A; Waibel R; Stahel RA
Br J Cancer; 1990 Sep; 62(3):410-4. PubMed ID: 2169852
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic activity of ricin A chain immunotoxins recognising cluster 1, w4 and 5A antigens associated with human small cell lung cancer.
Wawrzynczak EJ; Derbyshire EJ; Henry RV; Parnell GD; Smith A; Waibel R; Stahel RA
Br J Cancer Suppl; 1991 Jun; 14():71-3. PubMed ID: 1645577
[TBL] [Abstract][Full Text] [Related]
6. Anti-tumor activity of a blocked ricin immunotoxin with specificity against the cluster-5A antigen associated with human small-cell lung cancer.
Zangemeister-Wittke U; Collinson AR; Fisch I; Jones RM; Waibel R; Lehman HP; Stahel RA
Int J Cancer; 1993 Jul; 54(6):1028-35. PubMed ID: 8392978
[TBL] [Abstract][Full Text] [Related]
7. An anti-mucin immunotoxin BrE-3-ricin A-chain is potently and selectively toxic to human small-cell lung cancer.
Derbyshire EJ; Wawrzynczak EJ
Int J Cancer; 1992 Oct; 52(4):624-30. PubMed ID: 1328073
[TBL] [Abstract][Full Text] [Related]
8. Immunotoxins recognising a new epitope on the neural cell adhesion molecule have potent cytotoxic effects against small cell lung cancer.
Zangemeister-Wittke U; Collinson AR; Frösch B; Waibel R; Schenker T; Stahel RA
Br J Cancer; 1994 Jan; 69(1):32-9. PubMed ID: 7506925
[TBL] [Abstract][Full Text] [Related]
9. Blocked and non-blocked ricin immunotoxins against the CD4 antigen exhibit higher cytotoxic potency than a ricin A chain immunotoxin potentiated with ricin B chain or with a ricin B chain immunotoxin.
Wawrzynczak EJ; Watson GJ; Cumber AJ; Henry RV; Parnell GD; Rieber EP; Thorpe PE
Cancer Immunol Immunother; 1991; 32(5):289-95. PubMed ID: 1998970
[TBL] [Abstract][Full Text] [Related]
10. Elimination of neuroblastoma and small-cell lung cancer cells with an anti-neural cell adhesion molecule immunotoxin.
Roy DC; Ouellet S; Le Houillier C; Ariniello PD; Perreault C; Lambert JM
J Natl Cancer Inst; 1996 Aug; 88(16):1136-45. PubMed ID: 8757193
[TBL] [Abstract][Full Text] [Related]
11. Potent cytotoxic action of the immunotoxin SWA11-ricin A chain against human small cell lung cancer cell lines.
Derbyshire EJ; Henry RV; Stahel RA; Wawrzynczak EJ
Br J Cancer; 1992 Sep; 66(3):444-51. PubMed ID: 1325825
[TBL] [Abstract][Full Text] [Related]
12. Action of a CD24-specific deglycosylated ricin-A-chain immunotoxin in conventional and novel models of small-cell-lung-cancer xenograft.
Zangemeister-Wittke U; Lehmann HP; Waibel R; Wawrzynczak EJ; Stahel RA
Int J Cancer; 1993 Feb; 53(3):521-8. PubMed ID: 8381397
[TBL] [Abstract][Full Text] [Related]
13. Potentiation of a weakly active ricin A chain immunotoxin recognizing the neural cell adhesion molecule.
Derbyshire EJ; Stahel RA; Wawrzynczak EJ
Clin Exp Immunol; 1992 Sep; 89(3):336-40. PubMed ID: 1325302
[TBL] [Abstract][Full Text] [Related]
14. Immunotoxins to human small-cell lung cancer.
Wawrzynczak EJ; Derbyshire EJ
Cell Biophys; 1992; 21(1-3):13-23. PubMed ID: 1285325
[TBL] [Abstract][Full Text] [Related]
15. Characterization of two human small cell lung carcinoma-reactive monoclonal antibodies generated by a novel immunization approach.
Tong AW; Lee J; Stone MJ
Cancer Res; 1984 Nov; 44(11):4987-92. PubMed ID: 6207911
[TBL] [Abstract][Full Text] [Related]
16. Immunotoxin therapy of small-cell lung cancer: a phase I study of N901-blocked ricin.
Lynch TJ; Lambert JM; Coral F; Shefner J; Wen P; Blattler WA; Collinson AR; Ariniello PD; Braman G; Cook S; Esseltine D; Elias A; Skarin A; Ritz J
J Clin Oncol; 1997 Feb; 15(2):723-34. PubMed ID: 9053498
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of the specific cytotoxicity of a breast cancer-associated antigen immunotoxin by the carboxylic ionophore monensin.
Griffin TW; Pagnini PG; Houston LL
J Biol Response Mod; 1987 Oct; 6(5):537-45. PubMed ID: 3500277
[TBL] [Abstract][Full Text] [Related]
18. An assay that predicts the ability of monoclonal antibodies to form potent ricin A chain-containing immunotoxins.
Till M; May RD; Uhr JW; Thorpe PE; Vitetta ES
Cancer Res; 1988 Mar; 48(5):1119-23. PubMed ID: 3257712
[TBL] [Abstract][Full Text] [Related]
19. Rapid screening with indirect immunotoxin for monoclonal antibodies against human small cell lung cancer.
Weltman JK; Pedroso P; Johnson SA; Davignon D; Fast LD; Leone LA
Cancer Res; 1987 Nov; 47(21):5552-6. PubMed ID: 2822229
[TBL] [Abstract][Full Text] [Related]
20. Immunotoxin therapy of small-cell lung cancer. N901-blocked ricin for relapsed small-cell lung cancer.
Lynch TJ
Chest; 1993 Apr; 103(4 Suppl):436S-439S. PubMed ID: 8384975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
